0.000USD0.000Pre-market 07/24, 09:30 (ET)
48.35BMarket Cap
44.50P/E TTM
Edwards Lifesciences Corp
Key Figures
83.730Open
84.450High
6.91MVolume
44.50P/E TTM
25.13P/E Dynamic
--Dividend TTM
1.20%Turnover Ratio
84.370Prev. Close
82.990Low
305.30MTurnover
11.58P/E Static
4.68P/B
0.00%Div Yield TTM
8.15%ROA
88.28052wk High
1.38Volume Ratio
4.17BNet Profit
577.00MShares
1.8830EPS TTM
0.87Beta
10.52%ROE
72.30052wk Low
1.73%Amplitude
78.01%Gross Margin
48.35BMarket Cap
-4.12Reward/Risk
1.43%Risk Rate
Currency: USD Updated: 2026-07-23 Key Insights
Edwards Lifesciences Corp's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 9 out of 200 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 97.27.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Edwards Lifesciences Corp's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Edwards Lifesciences Corp Highlights
StrengthsRisks
Edwards Lifesciences Corp News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Edwards Lifesciences Corp
EW
32
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Thermo Fisher Scientific Inc
TMO
30
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Edwards Lifesciences Corp Info
Edwards Lifesciences Corporation is the global structural heart company. The Company partners with clinicians and researchers and invests in research and development to improve care for those impacted by structural heart disease. Its product categories include Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart. It provides transcatheter heart valve replacement technologies designed for the minimally-invasive replacement of aortic heart valves. TAVR category includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra and the Edwards SAPIEN 3 Ultra RESILIA systems. TMTT category includes the PASCAL Precision transcatheter repair system, EVOQUE tricuspid valve replacement system and Cardioband tricuspid valve reconstruction system. Its INSPIRIS RESILIA aortic valve, offers RESILIA tissue and VFit technology. It is managed in various geographical regions, such as United States, Europe, Japan and Rest of World.
Ticker SymbolEW
CompanyEdwards Lifesciences Corp
CEOZovighian (Bernard J)
Websitehttps://www.edwards.com
Shareholders
FAQs
What is the current price of Edwards Lifesciences Corp (EW)?
The current price of Edwards Lifesciences Corp (EW) is 83.80.
What is the symbol of Edwards Lifesciences Corp?
The ticker symbol of Edwards Lifesciences Corp is EW.
What is the 52-week high of Edwards Lifesciences Corp?
The 52-week high of Edwards Lifesciences Corp is 88.28.
What is the 52-week low of Edwards Lifesciences Corp?
The 52-week low of Edwards Lifesciences Corp is 72.30.
What is the market capitalization of Edwards Lifesciences Corp?
The market capitalization of Edwards Lifesciences Corp is 48.35B.
Is Edwards Lifesciences Corp (EW) currently rated as Buy, Hold, or Sell?
According to analysts, Edwards Lifesciences Corp (EW) has an overall rating of Buy, with a price target of 97.27.
What is the Earnings Per Share (EPS TTM) of Edwards Lifesciences Corp (EW)?
The Earnings Per Share (EPS TTM) of Edwards Lifesciences Corp (EW) is 1.84.
